JP3259960B2 - 細胞培養及び治療に有用なビタレテイン - Google Patents

細胞培養及び治療に有用なビタレテイン

Info

Publication number
JP3259960B2
JP3259960B2 JP51462891A JP51462891A JP3259960B2 JP 3259960 B2 JP3259960 B2 JP 3259960B2 JP 51462891 A JP51462891 A JP 51462891A JP 51462891 A JP51462891 A JP 51462891A JP 3259960 B2 JP3259960 B2 JP 3259960B2
Authority
JP
Japan
Prior art keywords
cells
cell
blocked
modulator
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP51462891A
Other languages
English (en)
Japanese (ja)
Other versions
JPH06500106A (ja
Inventor
ナイト，ガレン，ダリル
スカレン，テレンス，ジョセフ
Original Assignee
ユニバシテイ オブ ニュー メキシコ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユニバシテイ オブ ニュー メキシコ filed Critical ユニバシテイ オブ ニュー メキシコ
Publication of JPH06500106A publication Critical patent/JPH06500106A/ja
Application granted granted Critical
Publication of JP3259960B2 publication Critical patent/JP3259960B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0025—Culture media for plant cell or plant tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP51462891A 1990-07-06 1991-07-08 細胞培養及び治療に有用なビタレテイン Expired - Fee Related JP3259960B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US54910590A 1990-07-06 1990-07-06
US54944090A 1990-07-06 1990-07-06
US54943890A 1990-07-06 1990-07-06
US549,438 1990-07-06
US549,105 1990-07-06
US549,440 1990-07-06

Publications (2)

Publication Number Publication Date
JPH06500106A JPH06500106A (ja) 1994-01-06
JP3259960B2 true JP3259960B2 (ja) 2002-02-25

Family

ID=27415550

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51462891A Expired - Fee Related JP3259960B2 (ja) 1990-07-06 1991-07-08 細胞培養及び治療に有用なビタレテイン

Country Status (9)

Country Link
EP (1) EP0539525B1 (enExample)
JP (1) JP3259960B2 (enExample)
AT (1) ATE186048T1 (enExample)
AU (1) AU655598B2 (enExample)
DE (1) DE69131752T2 (enExample)
DK (1) DK0539525T3 (enExample)
ES (1) ES2139580T3 (enExample)
GR (1) GR3031801T3 (enExample)
WO (1) WO1992000955A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1018877A4 (en) * 1995-10-17 2000-08-09 Dovetail Technologies Inc LOW MOLECULAR WEIGHT STIMULANTS OF BONE MARROW AND IMMUNE SYSTEM CELLS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552765A (en) * 1982-05-14 1985-11-12 Santen Pharmaceutical Co., Ltd. Aletheine derivatives
EP0538330B1 (en) * 1990-07-06 1995-10-11 University Of New Mexico Beta-alethine use in cell culture and therapy

Also Published As

Publication number Publication date
EP0539525A4 (enExample) 1994-01-12
GR3031801T3 (en) 2000-02-29
EP0539525B1 (en) 1999-10-27
ES2139580T3 (es) 2000-02-16
DE69131752T2 (de) 2000-06-29
AU655598B2 (en) 1995-01-05
WO1992000955A1 (en) 1992-01-23
AU8500891A (en) 1992-02-04
DK0539525T3 (da) 2000-04-10
ATE186048T1 (de) 1999-11-15
DE69131752D1 (de) 1999-12-02
JPH06500106A (ja) 1994-01-06
EP0539525A1 (en) 1993-05-05
HK1014367A1 (en) 1999-09-24

Similar Documents

Publication Publication Date Title
JP5611967B2 (ja) イソプレニル化合物およびその方法。
AU718140B2 (en) Low molecular weight cell, bone marrow and immune stimulants
US6323025B1 (en) In vitro cell culture in media containing beta-alanyl-taurine or carbobenzoxy beta-alanyl-taurine
US5370868A (en) Therapeutic use of vitaletheine modulators in neoplasia
JP3259960B2 (ja) 細胞培養及び治療に有用なビタレテイン
JP3319597B2 (ja) 細胞培養及び治療に有用なβ―アレチン
EP3989967B1 (en) Compounds, compositions, and methods for protein degradation
US6046241A (en) β-alethine as anti-tumor agent
KR830001662B1 (ko) 포스파 닐릭산의 은 염류 제조방법
Knight et al. Vitalethine modulates erythropoiesis and neoplasia
US20030166715A1 (en) Use of vitaletheine modulators in the prophylaxis and treatment of disease
US6762174B1 (en) Low molecular weight compounds administered together with anti-cancer agents to prevent or treat cancer and pharmaceutical compositions thereof
US6245561B1 (en) β-alethine use in cell culture and therapy
SU990083A3 (ru) Способ получени производных сульфокислот 1,2-дигидрохинолина
CA2087884C (en) Vitaletheine and use in cell culture and therapy
CA2481110A1 (en) Vitaletheine and use in cell culture and therapy
HK1014367B (en) Vitaletheine and use in cell culture and therapy
AU2016348452A1 (en) Polyamine sulfonamides and uses thereof
CA2481077A1 (en) Beta-alethine use in cell culture and therapy
Barmore Relationship of chemotherapeutic agents to enzymes
UA22355U (en) Process for producing antitumor preparation

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees